Assessing Compass Therapeutics (CMPX) Valuation After Strong 1 Year Share Price Performance [Yahoo! Finance]
Compass Therapeutics, Inc. (CMPX)
Company Research
Source: Yahoo! Finance
Compass Therapeutics (CMPX) has drawn attention after recent share price moves, with the stock showing a 1.7% decline over the past day, alongside gains of 6.5% over the past week. Over the past month and the past 3 months, Compass Therapeutics has recorded returns of 14.9% and 33.8% respectively, while the 1-year total return sits at 119.2% and the year-to-date figure stands at 10.3%. See our latest analysis for Compass Therapeutics. At a share price of US$5.70, Compass Therapeutics has seen strong momentum lately, with a 30 day share price return of 14.9% and a 1 year total shareholder return of 119.2% pointing to building interest and shifting risk expectations around its clinical pipeline. If Compass has caught your eye and you are looking for more ideas in the same space, it could be a good time to scan other healthcare stocks that might fit your watchlist. With Compass Therapeutics posting a 119.2% 1 year total return and trading at US$5.70 versus an analyst price tar
Show less
Read more
Impact Snapshot
Event Time:
CMPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CMPX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CMPX alerts
High impacting Compass Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CMPX
News
- Is Compass Therapeutics (CMPX) Quietly Rewriting Its Oncology Strategy With New Commercial and Medical Chiefs? [Yahoo! Finance]Yahoo! Finance
- Compass Therapeutics Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Compass Therapeutics (NASDAQ:CMPX) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..MarketBeat
- Compass Therapeutics (NASDAQ:CMPX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.MarketBeat
- Compass Therapeutics Provides Corporate UpdateGlobeNewswire
CMPX
Earnings
- 8/11/25 - Miss
CMPX
Sec Filings
- 1/12/26 - Form 4
- 1/8/26 - Form EFFECT
- 1/6/26 - Form 8-K
- CMPX's page on the SEC website